Your Top 10 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Leora Horn, David Robert Spigel, Everett E. Vokes, Esther Holgado, Neal Ready, Martin B. Steins and 23 more
- Rank
- 9 of 667
- Percentile
- top 1.4%
- Where
- Journal of Clinical Oncology, 2017
- Citations
- 861
From the 2017 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.